Nitric oxide (NO): an emerging target for the treatment of glaucoma.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2014-08-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1167/iovs.14-14515PMID 25125670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility.

  2014cited by this paper
• Nipradilol promotes axon regeneration through S-nitrosylation of PTEN in retinal ganglion cells.

  2014cited by this paper
• Glaucoma management: relative value and place in therapy of available drug treatments

  2014cited by this paper
• MRP4-mediated regulation of intracellular cAMP and cGMP levels in trabecular meshwork cells and homeostasis of intraocular pressure.

  2013cited by this paper
• Soluble Guanylate Cyclase α1–Deficient Mice: A Novel Murine Model for Primary Open Angle Glaucoma

  2013cited by this paper
• Nitric oxide regulates AKT phosphorylation and nuclear translocation in cultured retinal cells.

  2013cited by this paper
• Effect of nitric oxide on anterior segment physiology in monkeys.

  2013influential reference
• The effect of Rho-associated protein kinase inhibitor on monkey Schlemm's canal endothelial cells

  2013cited by this paper
• DIDS inhibits Na-K-ATPase activity in porcine nonpigmented ciliary epithelial cells by a Src family kinase-dependent mechanism.

  2013cited by this paper
• Pathophysiology of Hypertension in the Absence of Nitric Oxide/Cyclic GMP Signaling

  2013cited by this paper
• Altered Expression of nNOS/NIDD in the Retina of a Glaucoma Model of DBA/2J Mice and the Intervention by nNOS Inhibition

  2013cited by this paper
• Differential effects of prostaglandin E2-sensitive receptors on contractility of human ocular cells that regulate conventional outflow.

  2013cited by this paper
• Current understanding of conventional outflow dysfunction in glaucoma

  2012cited by this paper
• No difference in genotype frequencies of polymorphisms of the nitric oxide pathway between Caucasian normal and high tension glaucoma patients

  2012cited by this paper
• Association of polymorphisms of endothelial nitric oxide synthase (eNOS) gene with the risk of primary open angle glaucoma in a Brazilian population.

  2012cited by this paper
• A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension

  2012influential reference
• Novel therapeutic strategies in the management of arterial hypertension.

  2012cited by this paper
• Protective action of nipradilol mediated through S-nitrosylation of Keap1 and HO-1 induction in retinal ganglion cells.

  2012cited by this paper
• The effect of Rho-associated protein kinase inhibitor on monkey Schlemm's canal endothelial cells.

  2012cited by this paper
• Effect of nitric oxide compounds on monkey ciliary muscle in vitro.

  2011cited by this paper
• Rho-Rho kinase pathway in the actomyosin contraction and cell-matrix adhesion in immortalized human trabecular meshwork cells

  2011cited by this paper
• Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.

  2011cited by this paper
• eNOS, a pressure-dependent regulator of intraocular pressure.

  2011influential reference
• A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs.

  2011cited by this paper
• Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects

  2010cited by this paper
• Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use.

  2010cited by this paper
• A Novel Nitric Oxide Releasing Prostaglandin Analog, NCX 125, Reduces Intraocular Pressure in Rabbit, Dog, and Primate Models of Glaucoma

  2010cited by this paper
• Episcleral venous pressure responses to topical nitroprusside and N-Nitro-L-arginine methyl ester.

  2010cited by this paper
• Aqueous Humor Dynamics: A Review

  2010cited by this paper
• Endogenous regulation of human Schlemm's canal cell volume by nitric oxide signaling.

  2010influential reference
• Route of penetration of topically instilled nipradilol into the ipsilateral posterior retina.

  2009cited by this paper
• Uveoscleral outflow--a review.

  2009cited by this paper
• Nitric oxide dilates rat retinal blood vessels by cyclooxygenase-dependent mechanisms.

  2009cited by this paper
• Discovery of the nitric oxide signaling pathway and targets for drug development.

  2009cited by this paper
• Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork.

  2009cited by this paper
• Correlation of In Vitro and In Vivo Kinetics of Nitric Oxide Donors in Ocular Tissues

  2009influential reference
• Neuroprotective Effect of Nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a Rat Model of Optic Nerve Degeneration

  2009cited by this paper
• Friend or foe? Resolving the impact of glial responses in glaucoma.

  2009cited by this paper
• The chemical biology of nitric oxide: implications in cellular signaling.

  2008cited by this paper
• NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel.

  2008cited by this paper
• Endogenous bioactive lipids and the regulation of conventional outflow facility

  2008cited by this paper
• Cross-talk between NO and arachidonic acid in inflammation.

  2007cited by this paper
• Nitric oxide: Ocular blood flow, glaucoma, and diabetic retinopathy

  2007influential reference
• Altered nitric oxide system in patients with open-angle glaucoma.

  2007cited by this paper
• Nitric oxide and peroxynitrite in health and disease.

  2007cited by this paper
• What is the present pathogenetic concept of glaucomatous optic neuropathy?

  2007cited by this paper
• Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model

  2007cited by this paper
• Axonal regeneration of cat retinal ganglion cells is promoted by nipradilol, an anti-glaucoma drug.

  2006cited by this paper
• Nitric Oxide and Posttranslational Modification of the Vascular Proteome: S-Nitrosation of Reactive Thiols

  2006cited by this paper
• NO donors inhibit Na,K‐ATPase activity by a protein kinase G‐dependent mechanism in the nonpigmented ciliary epithelium of the porcine eye

  2006cited by this paper
• Modulation of iNOS expression by a nitric oxide-releasing derivative of the natural antioxidant ferulic acid in activated RAW 264.7 macrophages.

  2006cited by this paper
• Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow.

  2005cited by this paper
• Potent reduction of intraocular pressure by nipradilol plus latanoprost in ocular hypertensive rabbits.

  2005influential reference
• Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage.

  2005cited by this paper
• S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding

  2005cited by this paper
• Cyclic GMP, sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye

  2005cited by this paper
• Role of anions in nitric oxide-induced short-circuit current increase in isolated porcine ciliary processes.

  2004cited by this paper
• Attenuation of chronic neuroinflammation by a nitric oxide‐releasing derivative of the antioxidant ferulic acid

  2004cited by this paper
• Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma

  2004cited by this paper
• Neuroprotective effect of nitric oxide against NMDA-induced neurotoxicity in the rat retina is associated with tyrosine hydroxylase expression.

  2003cited by this paper
• Retinal neuronal death induced by intraocular administration of a nitric oxide donor and its rescue by neurotrophic factors in rats.

  2003cited by this paper
• Nitric Oxide‐Induced Decrease in Calcium Sensitivity of Resistance Arteries Is Attributable to Activation of the Myosin Light Chain Phosphatase and Antagonized by the RhoA/Rho Kinase Pathway

  2003cited by this paper
• Nitric oxide regulates retinal vascular tone in humans.

  2003cited by this paper
• Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases.

  2003cited by this paper
• Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits

  2003cited by this paper
• Elevation of nitric oxide production in human trabecular meshwork by increased pressure

  2003cited by this paper
• Topical nipradilol: effects on optic nerve head circulation in humans and periocular distribution in monkeys.

  2002cited by this paper
• Comparison of Nitric Oxide Donors in Lowering Intraocular Pressure in Rabbits: Role of Cyclic GMP

  2002influential reference
• Decreased Nitric Oxide Production in Primary Open-Angle Glaucoma

  2002cited by this paper
• Nitric oxide/guanylate cyclase pathways and flow in anterior segment perfusion

  2002influential reference
• The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

  2002cited by this paper
• Vitreal glutamate concentration in monkeys with experimental glaucoma.

  2002cited by this paper
• A Prodrug of a Selective Inhibitor of Inducible Nitric Oxide Synthase is Neuroprotective in the Rat Model of Glaucoma

  2002cited by this paper
• Pharmacology and potential therapeutic applications of nitric oxide‐releasing non‐steroidal anti‐inflammatory and related nitric oxide‐donating drugs

  2002cited by this paper
• Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase.

  2002cited by this paper
• Elevated Nitric Oxide Level in Aqueous Humor of Patients with Acute Angle-Closure Glaucoma

  2001cited by this paper
• Dual action of nitric oxide on purely isolated retinal ganglion cells

  2001cited by this paper
• Intraocular Pressure and Vascular Effects of Sodium Azide in Bovine Perfused Eye

  2001cited by this paper
• Endothelium-dependent vasoactive modulation in the ophthalmic circulation.

  2001influential reference
• The effect of nipradilol, an a-ß blocker, on retinal blood flow in healthy volunteers

  2001cited by this paper
• Activation of Myosin Light Chain Phosphatase in Intact Arterial Smooth Muscle During Nitric Oxide-induced Relaxation*

  2001cited by this paper
• The effect of nipradilol, an alpha-beta blocker, on retinal blood flow in healthy volunteers.

  2001cited by this paper
• Paracrine neuroprotective effect of nitric oxide in the developing retina

  2001cited by this paper
• Carbachol and nitric oxide inhibition of Na,K-ATPase activity in bovine ciliary processes.

  2001cited by this paper
• Nitric Oxide: Biphasic Dose Responses

  2001cited by this paper
• Involvement of nitric oxide in the ocular hypotensive action of nipradilol

  2001cited by this paper
• Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action.

  2001cited by this paper
• Description of ciliary body anatomy and identification of sites for transscleral cyclophotocoagulation in the equine eye.

  2001cited by this paper
• Nitric oxide production by isolated human and porcine ciliary processes

  2000cited by this paper
• Nonadrenergic, noncholinergic relaxation of bovine iris sphincter: role of endogenous nitric oxide.

  2000cited by this paper
• Effects of topical nipradilol, a β blocking agent with α blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans

  2000cited by this paper
• Cyclic GMP-dependent Protein Kinase Signaling Pathway Inhibits RhoA-induced Ca2+ Sensitization of Contraction in Vascular Smooth Muscle*

  2000cited by this paper
• Inhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donors

  2000cited by this paper
• Human retinal hemodynamics following administration of 5-isosorbide mononitrate.

  2000cited by this paper
• Assessment of optic disk blood flow in patients with open-angle glaucoma.

  2000cited by this paper
• Effects of systemic NO synthase inhibition on choroidal and optic nerve head blood flow in healthy subjects.

  2000cited by this paper
• NO/cGMP pathway activation and membrane potential depolarization in pig ciliary epithelium.

  2000cited by this paper
• Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans.

  2000cited by this paper
• The dual personality of NO.

  2000cited by this paper
• The effect of L-arginine on intraocular pressure in the human eye.

  2000cited by this paper

• Dual-functional nanoparticle formulations for simultaneous intraocular pressure reduction and neuroprotection in glaucoma: a review.

  2026cites this paper
• Investigation of the effect of latanoprostene bunod and latanoprost on peripapillary optical coherence tomography angiography.

  2026cites this paper
• Effect of latanoprostene bunod 0.024% on ocular microcirculation measured by laser speckle flowgraphy in patients with open-angle glaucoma

  2026cites this paper
• IL-4Rα signalling influences behavioural and immune responses in Trypanosoma brucei-infected mice: Evidence for iloprost as a neuroprotective agent

  2025cites this paper
• Hybrid molecule SA-10 and its PLGA nanosuspension protect human and rodent retinal ganglion cells against neuronal injury

  2025cites this paper
• Intraocular pressure variation (ocular hypertension) in diabetes mellitus

  2025cites this paper
• Intraocular Pressure After Anti-Vascular Endothelial Growth Factor Injection in Eyes With a Mineralized Bruch's Membrane Caused by Pseudoxanthoma Elasticum

  2025cites this paper
• Association between Chronic Oral Nitrate Use and the Risk of Ocular Hypertension and Open-Angle Glaucoma.

  2025cites this paper
• Trabecular meshwork: A pivotal target for evolving glaucoma treatments.

  2025cites this paper
• Neuroprotective and intraocular pressure lowering effects of dual-functional memantine nitrate MN-08 on the experimental models of glaucoma

  2025cites this paper
• Platelet Membrane‐Camouflaged ROS‐Responsive Nanoplatform for Targeted Delivery and Sustained Release of Verteporfin to Modulate Hippo Signaling Pathway in Glaucoma Therapy

  2025cites this paper
• Evaluation of corneal and anterior segment alterations following short-term use of topical latanoprostene bunod

  2025cites this paper
• Permeation dynamics of organic moiety-tuned organosilica nanoparticles across porcine corneal barriers: experimental and mass transfer analysis for glaucoma drug delivery

  2025cites this paper
• Association Between Long-Term Ambient Air Pollution and Primary Open-Angle Glaucoma: A Nationwide Cohort Study in Taiwan.

  2025cites this paper
• Association of Inflammatory and Ischemic Markers with Posterior Segment Parameters in Pseudoexfoliation Syndrome and Glaucoma

  2025cites this paper
• Identification of Nitric Oxide Donating Dasatinib Derivatives with Intraocular Pressure Lowering and Senolytic Activities.

  2025cites this paper
• Biogenic Amino Acid Cross-Linked Hyaluronic Acid Nanoparticles Containing Dexamethasone for the Treatment of Dry Eye Syndrome

  2025cites this paper
• A Light‐Activatable Nitric Oxide Donor for Targeted Glaucoma Therapy with Real‐Time Monitoring Capabilities

  2025cites this paper
• Challenging glaucoma with emerging therapies: an overview of advancements against the silent thief of sight

  2025cites this paper
• Altered Biopterin-Related Cofactor Metabolism in the Aqueous Humor of Glaucoma Patients.

  2025cites this paper
• Medical glaucoma management: what's new on the horizon?

  2025cites this paper
• Chemical Insights into Topical Agents in Intraocular Pressure Management: From Glaucoma Etiopathology to Therapeutic Approaches

  2024cites this paper
• Eye yoga for glaucoma: recovery of vascular dysregulation and visual field function—a randomized controlled trial

  2024cites this paper
• Latanoprostene bunod: the first nitric oxide-donating antiglaucoma medication

  2024cites this paper
• Protective effect of Apelin-13 on oxygen and glucose deprivation induced-damage in retinal ganglion cells cultured in vitro

  2024cites this paper
• Lifestyle modifications and environmental risk factors for glaucoma

  2024cites this paper
• Glaucoma: Current and New Therapeutic Approaches

  2024cites this paper
• A Detailed Study of Glaucoma in Adults, Its Pathogenesis, Diagnosis and Management

  2024cites this paper
• Paper-based Electrochemical Sensor Integrated with Gold Nanoparticle-Decorated Carbon Cloth as a Working Electrode for Nitric Oxide Detection in Artificial Tears.

  2024cites this paper
• Effect of Bromfenac on Reducing Neuroinflammation in an Ischemia–Reperfusion Glaucoma Model

  2024cites this paper
• A Narrative Review of Pharmacotherapy of Glaucoma

  2024cites this paper
• The potential impact of a vegetarian diet on glaucoma.

  2024cites this paper
• Development of Cell Culture Platforms for Study of Trabecular Meshwork Cells and Glaucoma Development

  2024cites this paper
• A Randomized, Controlled Comparison of NCX 470, a Nitric Oxide-Donating Bimatoprost, and Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The MONT BLANC Study.

  2024cites this paper
• Factors Associated with Increased Intraocular Pressure in Type 2 Diabetes Patients

  2024cites this paper
• The Multifarious Effects of Various Glaucoma Pharmacotherapy on Corneal Endothelium: A Narrative Review

  2023cites this paper
• NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs

  2023cites this paper
• Factors in the development of refractory primary open-angle glaucoma (part 2)

  2023cites this paper
• Therapeutic Potential of Antioxidants and Hybrid TEMPOL Derivatives in Ocular Neurodegenerative Diseases: A Glimpse into the Future

  2023cites this paper
• Peroxynitrite-Scavenging Organosilica Nanomedicines for Light-Controllable NO Release and Precision On-Demand Glaucoma Therapy.

  2023cites this paper
• New Glaucoma Medications

  2023cites this paper
• NCX 470 Exerts Retinal Cell Protection and Enhances Ophthalmic Artery Blood Flow After Ischemia/Reperfusion Injury of Optic Nerve Head and Retina

  2023cites this paper
• Solving the New Puzzle(s) 2014-2022: Flammer Syndrome Probably Represents a Mild Endophenotype of Raynaud’s Phenomenon Mainly Associated with Ocular Disturbances and Also Due to Latent T. gondii Infection

  2023cites this paper
• Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells

  2023cites this paper
• Exploring the Relationship between Anti-VEGF Therapy and Glaucoma: Implications for Management Strategies

  2023cites this paper
• Diabetes more than retinopathy, it’s effect on the anterior segment of eye

  2023cites this paper
• Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma

  2023cites this paper
• FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma.

  2023cites this paper
• Effect of topical nitric oxide donors 0.03% nitroglycerin and 0.1% hydralazine on intraocular pressure in healthy canine eyes

  2022cites this paper
• Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities.

  2022cites this paper
• Latanoprostene Bunod 0.024% in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Meta-Analysis

  2022cites this paper
• GPR3 expression in retinal ganglion cells contributes to neuron survival and accelerates axonal regeneration after optic nerve crush in mice.

  2022cites this paper
• NCX 470 Restores Ocular Hemodynamics and Retinal Cell Physiology After ET-1-Induced Ischemia/Reperfusion Injury of Optic Nerve and Retina in Rabbits

  2022cites this paper
• From the PnTx2-6 Toxin to the PnPP-19 Engineered Peptide: Therapeutic Potential in Erectile Dysfunction, Nociception, and Glaucoma

  2022cites this paper
• Influence of Dinitrosyl Iron Complexes on the Activity of Enzymes, Indicators of Cardiovascular Diseases

  2022cites this paper
• IS A DECREASED NITRIC OXIDE CONCENTRATION AFTER TRIAMCINOLONE ACETONIDE INTRAVITREAL INJECTION ONE OF THE REASONS FOR INTRAOCULAR PRESSURE RISE?

  2022cites this paper
• A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites Study

  2022cites this paper
• Comparative effects of latanoprost and latanoprostene bunod on intraocular pressure and pupil size in ophthalmologically normal Beagle dogs.

  2022cites this paper
• Current situation and progress of drugs for reducing intraocular pressure

  2022cites this paper
• Neuroprotection of Rodent and Human Retinal Ganglion Cells In Vitro/Ex Vivo by the Hybrid Small Molecule SA-2

  2022cites this paper
• Updates on the Diagnosis and Management of Glaucoma

  2022cites this paper
• The role of nitric oxide in ocular surface physiology and pathophysiology.

  2021cites this paper
• Cell–Matrix Interactions in the Eye: From Cornea to Choroid

  2021cites this paper
• New considerations for the clinical efficacy of old and new topical glaucoma medications

  2021influential citation
• Is Mental Stress the Primary Cause of Glaucoma? Ist Stress die primäre Ursache von Glaukom?

  2021cites this paper
• NCX 667, a Novel Nitric Oxide Donor, Lowers Intraocular Pressure in Rabbits, Dogs, and Non-Human Primates and Enhances TGFβ2-Induced Outflow in HTM/HSC Constructs

  2021cites this paper
• NCX 1741, a Novel Nitric Oxide-Donating Phosphodiesterase-5 Inhibitor, Exerts Rapid and Long-Lasting Intraocular Pressure-Lowering in Cynomolgus Monkeys

  2021cites this paper
• The Application of Nitric Oxide for Ocular Hypertension Treatment

  2021cites this paper
• The role of Piezo1 in conventional aqueous humor outflow dynamics

  2021cites this paper
• CURRENT MEASURES AGAINST OPHTHALMIC COMPLICATIONS OF DIABETES MELLITUS-A SHORT REVIEW

  2021cites this paper
• The association between long-term exposure to ambient fine particulate matter and glaucoma: A nation-wide epidemiological study among Chinese adults.

  2021cites this paper
• Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies

  2021cites this paper
• Beneficial effect of mindfulness based stress reduction on optic disc perfusion in primary open angle glaucoma: A randomized controlled trial

  2021cites this paper
• Drugs for the treatment of glaucoma: Targets, structure-activity relationships and clinical research.

  2021cites this paper
• Endogenous dual stimuli-activated NO generation in the conventional outflow pathway for precision glaucoma therapy.

  2021cites this paper
• Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations

  2021cites this paper
• Extraction of capsanthin from Capsicum annum L fruits and its effect on carbomer-induced intraocular pressure in Albino Wistar rats.

  2021cites this paper
• Elevated dimethylarginine, ATP, cytokines, metabolic remodeling involving tryptophan metabolism and potential microglial inflammation characterize primary open angle glaucoma

  2021cites this paper
• The Neurovascular Unit in Glaucomatous Neurodegeneration

  2020cites this paper
• Medical Management of Glaucoma

  2020cites this paper
• Impact of nitric oxide's bidirectional role on glaucoma: focus on Helicobacter pylori–related nitrosative stress

  2020cites this paper
• Sustained nitric oxide-providing small molecule and precise release behavior study for glaucoma treatment.

  2020cites this paper
• Association of endothelial nitric oxide synthase (NOS3) gene polymorphisms with primary open-angle glaucoma in a Saudi cohort

  2020cites this paper
• Achieving Target IOP Through the Nitric Oxide Pathway

  2020cites this paper
• Imbalance Between Oxidative Stress and Growth Factors in Human High Myopia

  2020cites this paper
• The role of hemoglobin in nitric oxide transport in vascular system

  2020cites this paper
• Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye.

  2020cites this paper
• Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment

  2020cites this paper
• Tumor necrosis factor-alpha aggravates gliosis and inflammation of activated retinal Müller cells.

  2020cites this paper
• PnPP-19 Peptide as a Novel Drug Candidate for Topical Glaucoma Therapy Through Nitric Oxide Release

  2020cites this paper
• CurrentMedicalTherapyandFutureTrends in theManagementof Glaucoma Treatment

  2020cites this paper
• A thermoresponsive gel photoreleasing nitric oxide for potential ocular applications.

  2020cites this paper
• Physiologic Consequences of Caveolin-1 Ablation in Conventional Outflow Endothelia

  2020cites this paper
• A Review of New Medications and Future Directions of Medical Therapies in Glaucoma

  2020cites this paper
• Effect of dietary modification and antioxidant supplementation on intraocular pressure and open-angle glaucoma

  2020cites this paper
• Multifunctional glutathione-dependent hydrogel eye drops with enhanced drug bioavailability for glaucoma therapy

  2020cites this paper
• Effect of Mindfulness Meditation on Intraocular Pressure and Trabecular Meshwork Gene Expression: A Randomized Controlled Trial.

  2020cites this paper
• Influences of Hypomagnesemia on Optic Nerve and Retinal Vascular Structure Determined Using Optical Coherence Tomography (OCT) Angiography.

  2020cites this paper
• Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

  2020cites this paper
• Advances in medical therapy for glaucoma

  2020cites this paper